Invesaro

Stocks ARCO Financial statements

Financial statements

Arcos Dorados Holdings Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Arcos Dorados Holdings Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2,9293,3203,0822,9591,9842,6603,6194,3324,4704,678
Cost of revenue67.961.343.550.66883.483.789.5
Gross profit3,0142,8981,9412,6093,5514,2494,3864,589
General and administrative221245229213171211239285280313
Operating income179273123160-66.8140264314325364
Interest expense66.968.452.952.133.449.543.832.347.213.7
Other non-operating income-2.36-0.440.27-2.12.32.19-0.29-1.24-3.87-1.48
Pre-tax income13918385.2119-13277.8226278259341
Income tax59.653.348.138.817.531.985.595.7110129
Net income to minority interests0.180.330.190.220.070.370.581.140.620.47
Net income78.812936.879.9-14945.5140181149212
EBITDA27237222928360.1260384463502562
EPS, basic0.370.610.180.39-0.720.220.670.860.711.01
EPS, diluted0.370.610.180.38-0.720.220.670.860.711.01
Shares, basic (weighted)211211209207208210211211211211
Shares, diluted (weighted)211212210208209211211211211211
Dividend per share0.000.000.100.110.050.150.190.240.24

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents195308197122166279267197135373
Short-term investments019.600.030037.550.13.5348.9
Receivables83.211184.399.994.282.2124148119164
Inventory48.982.746.137.833.637.850.152.851.766.4
Other current assets3.630.970.410.320.811.211.441.20.710.23
Total current assets445653465405416540684605468852
Property, plant and equipment8488918569617977448561,1201,1271,309
Lease right-of-use assets9227917648219559501,134
Goodwill7.127.085.946.785.65.217.2311.913.316.6
Intangible assets35.940.735.136.331.433.647.358.153.3132
Other non-current assets89.798.39995.872.371.481.710493.6252
Total assets1,5051,8041,5782,5582,2942,3612,6373,0192,8933,886
Accounts payable218303242260210269353375348357
Deferred revenue1.586.8216.6
Short-term debt28.14.363.843.233.134.74191.82.6211.8
Total current liabilities548606493595503618759842766829
Long-term debt5526296266247737397127137161,126
Lease liabilities15.216.48627537077488538491,001
Other non-current liabilities9.9814.20.52.372.491.30.29000.61
Total liabilities1,1531,3081,1852,1362,0962,1402,3122,5022,3833,114
Total debt5806346306277777447317157191,138
Paid-in capital13.814.214.913.411.510.19.218.728.668.66
Retained earnings272401413471291316425566664826
Treasury stock0-46-60-39.5-19.4-19.4-19.4-19.4-19.4
Other comprehensive income-442-429-502-520-585-608-613-563-668-568
Shareholders' equity351496392421198220324515508770
Minority interests0.590.490.380.430.470.730.81.561.351.65
Total equity352496393422198221324517509772
Total liabilities and equity1,5051,8041,5782,5582,2942,3612,6373,0192,8933,886
Shares outstanding211211205204207210211211211

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income791293780.1-14945.9141182149213
Depreciation and amortization9399.4106123127120120149177197
Deferred income tax5.52.10.65-7.970.47-16.1-15.4-4.31-11.4-4.85
Change in inventory-6.044.83-4.25-9.29
Change in payables35.810316.639.4
Cash from operations16425518022316258345382267296
Capital expenditures-92.3-175-197-265-86.3-115-217-360-328-281
Acquisitions-0.870-2.66-3.83-0.19-4.8-2.08-6.08-7.06
Purchases of investments0-19.6
Cash from investing23-124-164-261-88.7-108-260-380-280-335
Debt repaid-22.90-379
Share buybacks00-46-1400
Dividends paid00-20.9-22.4-10.2-0.02-31.6-40-50.6-50.6
Cash from financing-113-3.35-73.4-29.6126-17.9-60-11.8-37.2289
Exchange rate effect8.07-13.6-53.7-8.26-9.16-19-37.7-60.1-11-11.7
Net change in cash82.3114-111-75.444.1113-11.9-70.3-61.6238
Free cash flow71.980.4-17.3-41.8-70.314312821.9-60.815
Interest paid76.653.255.452.557.152.656.447.55259.4
Income taxes paid39.124.132.234.122.534.578.972.8121116

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $7.24 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin98.1%Gross profit / revenue.
Operating margin7.8%Operating income / revenue.
EBITDA margin12.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin7.3%Pre-tax income / revenue.
Net margin4.5%Net income / revenue.
FCF margin0.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.3%Cash from operations / revenue.
Effective tax rate37.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)33.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.3%Net income / average total assets.
Return on invested capital (ROIC)17.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue6.0%Capital expenditures / revenue.
D&A / revenue4.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y18.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y4.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y18.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y12.3%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y11.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y11.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y13.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y56.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y42.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y14.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y42.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y14.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y11.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-5.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y79.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y-51.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y17.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y36.9%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y51.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y33.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y31.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y34.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y13.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y11.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.03xCurrent assets / current liabilities.
Quick ratio0.71x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.51x(Cash + short-term investments) / current liabilities.
Debt / equity1.48xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets29.3%Total debt / total assets.
Liabilities / assets80.1%Total liabilities / total assets.
Net debt$715.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.27xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage26.7xOperating income / interest expense.
Working capital$23.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets3.8%(Goodwill + intangible assets) / total assets.
Tangible book value$621.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.38xRevenue / average total assets.
Fixed asset turnover3.84xRevenue / average property, plant and equipment.
Inventory turnover1.52xCost of revenue / average inventory.
Days inventory241 days365 x average inventory / cost of revenue.
Receivables turnover33.0xRevenue / average receivables.
Days sales outstanding11 days365 x average receivables / revenue.
Days payables1,436 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-1,185 daysDays inventory + days sales outstanding - days payables.
FCF conversion7.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow94.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.01Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$1.01Net income per basic share, as reported (split-adjusted).
Revenue per share$22.21Revenue / diluted weighted shares.
FCF per share$0.07Free cash flow / diluted weighted shares.
Operating cash flow per share$1.41Cash from operations / diluted weighted shares.
Book value per share$3.66Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.95Tangible book value / shares outstanding.
Cash per share$2.00(Cash + short-term investments) / shares outstanding.
Dividend per share$0.24Dividend declared per common share (paid, when declared is not tagged).
Payout ratio23.8%Dividends paid / net income, when net income is positive.
Dividends / FCF337.2%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.53BShare price x shares outstanding.
Enterprise value$2.24BMarket cap + total debt - cash - short-term investments.
P/E7.19xMarket cap / net income. Only when net income is positive.
P/S0.33xMarket cap / revenue.
P/B1.98xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.45xMarket cap / tangible book value, when positive.
P/FCF102xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF5.15xMarket cap / cash from operations, when positive.
EV/Sales0.48xEnterprise value / revenue.
EV/EBIT6.15xEnterprise value / operating income, when both are positive.
EV/EBITDA3.99xEnterprise value / EBITDA, when both are positive.
EV/FCF149xEnterprise value / free cash flow, when both are positive.
FCF yield1.0%Free cash flow / market cap.
Earnings yield13.9%Net income / market cap (the inverse of P/E).
Dividend yield3.3%Dividends paid over the period / market cap.
Shareholder yield3.3%(Dividends paid + share buybacks) / market cap.
PEG0.49xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Arcos Dorados Holdings Inc.'s revenue in fiscal 2025?

Arcos Dorados Holdings Inc. reported revenue of $4.68B for fiscal 2025, 4.7% higher than the year before.

Was Arcos Dorados Holdings Inc. profitable in fiscal 2025?

Yes. Net income was $212.1M, a net margin of 4.5%.

How much free cash flow did Arcos Dorados Holdings Inc. generate in fiscal 2025?

Cash from operations of $296.3M minus capital expenditures of $281.4M left free cash flow of $15.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Arcos Dorados Holdings Inc.